2024-517377-24-00CompletedPhase 1
Cardiac safety of treosulfan chemotherapy prior to stem cell transplantation in patients with leukemia.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 25 Apr 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 20 Sept 2024
- Start date
- 20 Dec 2022
- Lead sponsor
- Medac Gesellschaft fuer klinische Spezialpraeparate mbH
- EU CT number
- 2024-517377-24-00
- EudraCT number
- 2021-005433-16
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 30
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (4)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Technische Universitaet Dresden | Dresden | Germany | Completed |
| Universitaetsklinikum Essen (AoR) | Essen | Germany | Completed |
| Universitaetsklinikum Schleswig-Holstein AöR | Kiel | Germany | Completed |
| Universitaet Muenster | Muenster | Germany | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.